NEW YORK (GenomeWeb News) – Celera subsidiary Berkeley HeartLab will use GenVault's biosample preservation and storage technology for use in its clinical lab testing business, GenVault said today.
GenVault's GenTegra DNA technology is used to stabilize purified DNA biosamples with antimicrobial activity for dry, room temperature transport and biobanking. Purified DNA dried within the GenTegra DNA platform is fully resolubilized with water for direct downstream molecular analysis, the company said.
The platform is a scalable and environmentally friendly alternative to freezers and nucleic acid purification systems, and enables the extraction, preservation, recovery, and distribution of biosamples at ambient temperature, Carlsbad, Calif.-based GenVault said.
Financial terms of the agreement were not released.